Characterization of functional domains within Smad4/DPC4

被引:134
作者
deCaestecker, MP
Hemmati, P
LarischBloch, S
Ajmera, R
Roberts, AB
Lechleider, RJ
机构
[1] Laboratory of Chemoprevention, NCI, National Institutes of Health, Bethesda
[2] Laboratory of Chemoprevention, NCI, Bldg. 41, Bethesda, MD 20892-5055
关键词
D O I
10.1074/jbc.272.21.13690
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Smad proteins are a family of highly conserved, intracellular proteins that signal cellular responses downstream of transforming growth factor-beta (TGF-beta) family serine/threonine kinase receptors. One of these molecules, Smad4, originally identified as the candidate tumor suppressor gene dpc-4, reconstitutes TGF-beta- and activin-dependent transcriptional responses in Smad4 null cell lines and interacts in a ligand-dependent manner with other Smad family members in both TGF-beta, activin, and bone morphogenetic protein-2/-4 pathways. Here, we used an assay based on the restoration of ligand-dependent transcriptional responses in a Smad4 null cell line to characterize functional domain structures within Smad4. We showed that restoration of TGF-beta-induced transcriptional responses by Smad4 was inhibited by co-transfection with a kinase dead TGF-beta type II receptor and that constitutive activation was blocked with TGF-beta neutralizing antibodies, confirming the essential role of Smad4 in TGF-beta signaling. Using a series of Smad4 mutation, deletion, and Smad1/Smad4 chimera constructs we identified a 47-amino acid deletion within the middle-linker region of Smad4 that is essential for the mediation of signaling responses. In addition, we showed that the NH2-terminal domain of Smad4 augments ligand-dependent activation associated with the middle-linker region, indicating that there is a distinct ligand-response domain within the N terminus of this molecule.
引用
收藏
页码:13690 / 13696
页数:7
相关论文
共 25 条
[1]
A novel mesoderm inducer, Madr2 functions in the activin signal transduction pathway [J].
Baker, JC ;
Harland, RM .
GENES & DEVELOPMENT, 1996, 10 (15) :1880-1889
[2]
INACTIVE TYPE-II AND TYPE-I RECEPTORS FOR TGF-BETA ARE DOMINANT INHIBITORS OF TGF-BETA-DEPENDENT TRANSCRIPTION [J].
BRAND, T ;
SCHNEIDER, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :8274-8284
[3]
A transcriptional partner for MAD proteins in TGF-beta signalling [J].
Chen, X ;
Rubock, MJ ;
Whitman, M .
NATURE, 1996, 383 (6602) :691-696
[4]
IMMUNODETECTION AND QUANTITATION OF THE 2 FORMS OF TRANSFORMING GROWTH FACTOR-BETA (TGF-BETA-1 AND TGF-BETA-2) SECRETED BY CELLS IN CULTURE [J].
DANIELPOUR, D ;
DART, LL ;
FLANDERS, KC ;
ROBERTS, AB ;
SPORN, MB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 138 (01) :79-86
[5]
MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma [J].
Eppert, K ;
Scherer, SW ;
Ozcelik, H ;
Pirone, R ;
Hoodless, P ;
Kim, H ;
Tsui, LC ;
Bapat, B ;
Gallinger, S ;
Andrulis, IL ;
Thomsen, GH ;
Wrana, JL ;
Attisano, L .
CELL, 1996, 86 (04) :543-552
[6]
FROLIK CA, 1984, J BIOL CHEM, V259, P995
[7]
GELBART WM, 1989, DEVELOPMENT, V107, P65
[8]
INDUCTION AND AUTOCRINE RECEPTOR-BINDING OF TRANSFORMING GROWTH FACTOR-BETA-2 DURING TERMINAL DIFFERENTIATION OF PRIMARY MOUSE KERATINOCYTES [J].
GLICK, AB ;
DANIELPOUR, D ;
MORGAN, D ;
SPORN, MB ;
YUSPA, SH .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (01) :46-52
[9]
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353
[10]
MADR1, a MAD-related protein that functions in BMP2 signaling pathways [J].
Hoodless, PA ;
Haerry, T ;
Abdollah, S ;
Stapleton, M ;
OConnor, MB ;
Attisano, L ;
Wrana, JL .
CELL, 1996, 85 (04) :489-500